Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
April 18, 2024 16:05 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD)...
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global) 2024
April 18, 2024 07:30 ET
|
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and
Investigator-Initiated Pre-Clinical Studies at ESCMID Global (Formerly ECCMID)
Q1 2024 Revenue and Business Update
April 17, 2024 03:05 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, April 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the...
Astaxanthin Market size worth $ 92.81 Billion, Globally, by 2031 at 2.38% CAGR – Report By Verified Market Research®
April 16, 2024 10:15 ET
|
Verified Market Research
Jersey City, New Jersey, April 16, 2024 (GLOBE NEWSWIRE) -- The Global Astaxanthin Market is projected to grow at a CAGR of 2.38% from 2024 to 2031, according to a new report published by Verified...
QSAM ANNOUNCES REVERSE STOCK SPLIT RATIO AHEAD OF MERGER
April 16, 2024 08:30 ET
|
QSAM Biosciences Inc.
Austin, TX, April 16, 2024 (GLOBE NEWSWIRE) -- QSAM Biosciences, Inc. (OTCQB: QSAM) (“QSAM” or the “Company”) previously announced that it will effectuate a reverse stock split of the issued and...
TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation
April 15, 2024 18:27 ET
|
Telix Pharmaceuticals Limited
FDA Fast Track designation granted for TLX101-CDx for glioma (brain cancer) imagingCollaboration agreement announced for joint development and commercialisation with UCSF PharmaLogic announced as...
Asia Pharmaceutical Directory 2024: Top Source of Information on 10,000 Pharmaceutical and Biotechnology Companies
April 15, 2024 11:19 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Asian Pharmaceutical Directory 2024" directory has been added to ResearchAndMarkets.com's offering.Keep up-to-date with the Asian Pharmaceutical...
Global Pharma Handbook 2024: Expanded Coverage of Health Systems, Sales, Demand Profiles, Clinical Trials, Drug Approval Procedures, Regulatory Policies, IP, Pricing, Marketing, Generics
April 15, 2024 09:06 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Global Pharma Handbook 2024" directory has been added to ResearchAndMarkets.com's offering.The Global Pharma Handbook includes expanded coverage of...
European and USA Pharmaceutical Directory 2024: Indispensable Guide for Key Decision-makers
April 15, 2024 09:04 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "European and USA Pharmaceutical Directory 2024" directory has been added to ResearchAndMarkets.com's offering.The European & USA Pharmaceutical...
Global Directory Unveils Top 1,000 Pharmaceutical and Biotechnology Companies for 2024
April 15, 2024 09:02 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Major Pharmaceutical Companies 2024" report has been added to ResearchAndMarkets.com's offering. In an era of rapid technological advancements and...